I  Vanderbilt University Center for Technology Transfer and Commercialization

http://www.vanderbilt.edu/technology_transfer





     Office Locations:

Center for Technology Transfer and Commercialization
1207 17th Avenue South, Suite 105
Nashville, TN 37212
Phone: 615-343-2430
Fax: 615-343-4419

 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Vanderbilt University's Center for Technology Transfer and Commercialization provides a variety of intellectual property-related services to Vanderbilt researchers, including innovation identification, protection, marketing and licensing. The Center also works with investment professionals, angel investors and experienced management teams to identify technologies that are appropriate for a commercialization strategy involving a start-up company. Vanderbilt currently maintains a portfolio of 20 active start-up companies that span a range of technologies including computerized surgical navigation, natural products for insect control, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy and healthcare services. In fiscal year 2012, 40 U.S. patents were issued for Vanderbilt technologies, and 60 new licenses were granted to facilitate the transfer of scientific discovery and innovation to the commercial marketplace.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alan Bentley M.S. Assistant Vice Chancellor
    Ashok Choudhury Ph.D. Senior Licensing Officer
    Chris Harris Director of Licensing
    Janis Elsner Director of Commercial Operations
    Karen Rufus Senior Licensing Manager Biotech

     

    Portfolio companies include:


      Acuitec
        web link


      American Sentinel University
        web link


      Applied Health Analytics
        web link


      Appliflex
        web link


      AssistMed
        web link


      Cardiovascular Care Affiliates
        web link


      Cumberland Emerging Technologies
        web link


      HealthGate
        web link


      Informatics Corporation of America
        web link


      KaiNexus
        web link


      LifeWings
        web link


      Microarrays
        web link


      Molecular Sensing
        web link


      MXISystems
        web link


      NephroGenex
        web link


      Pathfinder Therapeutics


      Protein Discovery
        web link


      Stem Cell Innovations
        web link


      TyraTech
        web link


      Universal Robotics
        web link


      Zirus
        web link


     

    Recent News:


      There is no recent news for Vanderbilt University Center for Technology Transfer and Commercialization.